Kiora Pharmaceuticals Stock Price History
| KPRX Stock | USD 3.31 0.11 3.22% |
Below is the normalized historical share price chart for Kiora Pharmaceuticals extending back to February 13, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Kiora Pharmaceuticals stands at 3.31, as last reported on the 21st of November, with the highest price reaching 3.41 and the lowest price hitting 3.31 during the day.
If you're considering investing in Kiora Stock, it is important to understand the factors that can impact its price. Kiora Pharmaceuticals has Sharpe Ratio of -0.039, which conveys that the firm had a -0.039% return per unit of risk over the last 3 months. Kiora Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Kiora Pharmaceuticals' Standard Deviation of 3.73, risk adjusted performance of (0.03), and Mean Deviation of 2.77 to check out the risk estimate we provide.
At this time, Kiora Pharmaceuticals' Total Stockholder Equity is fairly stable compared to the past year. Common Stock Shares Outstanding is likely to rise to about 564.9 K in 2024, whereas Liabilities And Stockholders Equity is likely to drop slightly above 11.7 M in 2024. . At this time, Kiora Pharmaceuticals' Price To Sales Ratio is fairly stable compared to the past year. Price Book Value Ratio is likely to rise to 0.43 in 2024, whereas Price Earnings Ratio is likely to drop (0.21) in 2024. Kiora Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 31st of July 2015 | 200 Day MA 4.5038 | 50 Day MA 3.529 | Beta (0.29) |
Kiora |
Sharpe Ratio = -0.039
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | KPRX |
Estimated Market Risk
| 3.59 actual daily | 31 69% of assets are more volatile |
Expected Return
| -0.14 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.04 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Kiora Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Kiora Pharmaceuticals by adding Kiora Pharmaceuticals to a well-diversified portfolio.
Price Book 0.3417 | Enterprise Value Ebitda (1.03) | Price Sales 0.6406 | Shares Float 1.4 M | Wall Street Target Price 30.33 |
Kiora Pharmaceuticals Stock Price History Chart
There are several ways to analyze Kiora Stock price data. The simplest method is using a basic Kiora candlestick price chart, which shows Kiora Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | October 28, 2024 | 4.04 |
| Lowest Price | October 14, 2024 | 3.1 |
Kiora Pharmaceuticals November 21, 2024 Stock Price Synopsis
Various analyses of Kiora Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Kiora Stock. It can be used to describe the percentage change in the price of Kiora Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Kiora Stock.| Kiora Pharmaceuticals Accumulation Distribution | 90.88 | |
| Kiora Pharmaceuticals Price Rate Of Daily Change | 0.97 | |
| Kiora Pharmaceuticals Price Daily Balance Of Power | (1.10) | |
| Kiora Pharmaceuticals Price Action Indicator | (0.10) |
Kiora Pharmaceuticals November 21, 2024 Stock Price Analysis
Kiora Stock Price History Data
The price series of Kiora Pharmaceuticals for the period between Fri, Aug 23, 2024 and Thu, Nov 21, 2024 has a statistical range of 1.01 with a coefficient of variation of 5.4. The daily prices for the period are spread out with arithmetic mean of 3.55. The median price for the last 90 days is 3.54. The company underwent 1:9 stock split on 11th of June 2024. Kiora Pharmaceuticals issued dividends to stockholders on 2019-08-30.| Open | High | Low | Close | Volume | ||
| 11/21/2024 | 3.42 | 3.41 | 3.31 | 3.31 | 3,099 | |
| 11/20/2024 | 3.27 | 3.49 | 3.27 | 3.42 | 16,182 | |
| 11/19/2024 | 3.25 | 3.39 | 3.20 | 3.23 | 11,820 | |
| 11/18/2024 | 3.25 | 3.32 | 3.22 | 3.22 | 14,606 | |
| 11/15/2024 | 3.38 | 3.38 | 3.16 | 3.29 | 34,019 | |
| 11/14/2024 | 3.53 | 3.59 | 3.38 | 3.40 | 14,034 | |
| 11/13/2024 | 3.62 | 3.76 | 3.43 | 3.44 | 30,038 | |
| 11/12/2024 | 3.70 | 3.80 | 3.61 | 3.62 | 22,792 | |
| 11/11/2024 | 3.67 | 3.80 | 3.62 | 3.74 | 30,676 | |
| 11/08/2024 | 3.68 | 3.68 | 3.47 | 3.53 | 13,464 | |
| 11/07/2024 | 3.57 | 3.59 | 3.50 | 3.57 | 12,669 | |
| 11/06/2024 | 3.60 | 3.68 | 3.52 | 3.52 | 11,944 | |
| 11/05/2024 | 3.73 | 3.75 | 3.52 | 3.52 | 19,721 | |
| 11/04/2024 | 3.61 | 3.74 | 3.46 | 3.68 | 32,364 | |
| 11/01/2024 | 3.54 | 3.69 | 3.51 | 3.60 | 25,258 | |
| 10/31/2024 | 3.76 | 3.77 | 3.56 | 3.62 | 11,895 | |
| 10/30/2024 | 3.85 | 3.85 | 3.60 | 3.70 | 19,894 | |
| 10/29/2024 | 3.91 | 3.91 | 3.42 | 3.85 | 453,372 | |
| 10/28/2024 | 3.74 | 4.15 | 3.70 | 4.04 | 124,095 | |
| 10/25/2024 | 3.63 | 3.64 | 3.55 | 3.64 | 13,551 | |
| 10/24/2024 | 3.52 | 3.63 | 3.47 | 3.62 | 33,500 | |
| 10/23/2024 | 3.43 | 3.52 | 3.43 | 3.52 | 10,179 | |
| 10/22/2024 | 3.42 | 3.50 | 3.42 | 3.49 | 12,934 | |
| 10/21/2024 | 3.41 | 3.54 | 3.41 | 3.49 | 8,038 | |
| 10/18/2024 | 3.33 | 3.47 | 3.26 | 3.47 | 12,829 | |
| 10/17/2024 | 3.43 | 3.58 | 3.31 | 3.31 | 32,973 | |
| 10/16/2024 | 3.13 | 3.46 | 3.13 | 3.40 | 35,198 | |
| 10/15/2024 | 3.13 | 3.26 | 3.13 | 3.20 | 8,922 | |
| 10/14/2024 | 3.40 | 3.45 | 3.08 | 3.10 | 22,677 | |
| 10/11/2024 | 3.30 | 3.44 | 3.27 | 3.44 | 5,040 | |
| 10/10/2024 | 3.35 | 3.44 | 3.26 | 3.26 | 6,898 | |
| 10/09/2024 | 3.43 | 3.43 | 3.36 | 3.36 | 1,333 | |
| 10/08/2024 | 3.35 | 3.44 | 3.34 | 3.44 | 6,291 | |
| 10/07/2024 | 3.45 | 3.50 | 3.25 | 3.31 | 19,020 | |
| 10/04/2024 | 3.56 | 3.56 | 3.38 | 3.46 | 15,012 | |
| 10/03/2024 | 3.70 | 3.70 | 3.42 | 3.49 | 13,650 | |
| 10/02/2024 | 3.56 | 3.63 | 3.48 | 3.63 | 10,297 | |
| 10/01/2024 | 3.67 | 3.69 | 3.47 | 3.57 | 20,530 | |
| 09/30/2024 | 3.43 | 3.66 | 3.38 | 3.66 | 10,942 | |
| 09/27/2024 | 3.50 | 3.50 | 3.37 | 3.43 | 10,673 | |
| 09/26/2024 | 3.49 | 3.49 | 3.44 | 3.45 | 5,559 | |
| 09/25/2024 | 3.53 | 3.53 | 3.44 | 3.45 | 4,090 | |
| 09/24/2024 | 3.66 | 3.66 | 3.40 | 3.44 | 11,891 | |
| 09/23/2024 | 3.69 | 3.73 | 3.62 | 3.62 | 5,063 | |
| 09/20/2024 | 3.65 | 3.88 | 3.63 | 3.66 | 12,712 | |
| 09/19/2024 | 3.72 | 3.80 | 3.65 | 3.72 | 10,657 | |
| 09/18/2024 | 3.50 | 3.78 | 3.42 | 3.62 | 41,789 | |
| 09/17/2024 | 3.41 | 3.54 | 3.36 | 3.46 | 14,025 | |
| 09/16/2024 | 3.65 | 3.65 | 3.33 | 3.41 | 34,377 | |
| 09/13/2024 | 3.62 | 3.70 | 3.51 | 3.66 | 16,257 | |
| 09/12/2024 | 3.62 | 3.74 | 3.54 | 3.62 | 17,284 | |
| 09/11/2024 | 3.62 | 3.89 | 3.52 | 3.58 | 31,650 | |
| 09/10/2024 | 3.55 | 3.77 | 3.47 | 3.50 | 16,502 | |
| 09/09/2024 | 3.50 | 3.65 | 3.46 | 3.46 | 2,207 | |
| 09/06/2024 | 3.50 | 3.57 | 3.45 | 3.54 | 6,069 | |
| 09/05/2024 | 3.64 | 3.65 | 3.51 | 3.52 | 3,597 | |
| 09/04/2024 | 3.52 | 3.60 | 3.50 | 3.56 | 5,712 | |
| 09/03/2024 | 3.70 | 3.70 | 3.52 | 3.54 | 9,608 | |
| 08/30/2024 | 3.71 | 3.79 | 3.70 | 3.70 | 9,090 | |
| 08/29/2024 | 3.75 | 3.77 | 3.71 | 3.71 | 4,204 | |
| 08/28/2024 | 3.85 | 3.87 | 3.75 | 3.75 | 2,980 |
About Kiora Pharmaceuticals Stock history
Kiora Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Kiora is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Kiora Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Kiora Pharmaceuticals stock prices may prove useful in developing a viable investing in Kiora Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 538 K | 564.9 K | |
| Net Loss | -14.8 M | -15.5 M |
Kiora Pharmaceuticals Quarterly Net Working Capital |
|
Kiora Pharmaceuticals Stock Technical Analysis
Kiora Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Stocks Directory Now
Stocks DirectoryFind actively traded stocks across global markets |
| All Next | Launch Module |
Kiora Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Kiora Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Kiora Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Kiora to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.29) | |||
| Total Risk Alpha | (0.64) | |||
| Treynor Ratio | (0.26) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Kiora Stock Analysis
When running Kiora Pharmaceuticals' price analysis, check to measure Kiora Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kiora Pharmaceuticals is operating at the current time. Most of Kiora Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Kiora Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kiora Pharmaceuticals' price. Additionally, you may evaluate how the addition of Kiora Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.